8 results
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
EBM #Neurology #Stroke ... NegativeTrials #TPA ... Thrombolytics #Evidence ... #Summary #TPADebate ... #Controversy #CVA
Summary of All RCTs to Date on Endovascular Therapy for Acute Ischemic Stroke 

#EBM #Neurology #NeuroInterventionalRadiology
Summary of All RCTs ... Acute Ischemic Stroke ... EndovascularTherapy #Stroke ... #CVA #RCT #Summary ... #Table
Thrombolytics for stroke: The evidence - 
A summary of the evidence for (or against) thrombolytics for
: The evidence - ... A summary of ... the evidence for ... Here is a nice table ... #Summary #TPADebate
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... Table Insulin ... Eric Strong @DrEricStrong ... - Strong Medicine ... #medications #table
Common Arguments and Rebuttals on tPA in Acute Stroke - George Mastoras, MD @georgemastoras
#EBM #Neuro #Stroke
and Rebuttals on tPA ... in Acute Stroke ... #EBM #Neuro #Stroke ... #Thrombolysis #Evidence ... #Summary
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... Ozempic), or daily tablet ... variety of adverse CV ... - Strong Medicine ... #Pharmacology #Summary
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
exam (any evidence ... b) CHF c) CVA ... event, follow ACC algorithm ... Stable patients ... • <6mo since stroke
Polycythemia Vera (PV) - Diagnosis and Management Summary
Diagnostic Criteria:
 • Elevated hemoglobin and/or hematocrit AND
 •
and Management Summary ... • Treatment algorithms ... patients with evidence ... Eric Strong @DrEricStrong ... - Strong Medicine